Trevi provides development and growth capital for private healthcare companies with emphasis on medical devices, biopharmaceuticals and healthcare services.
The firm was founded in 2005 and has offices in New York and London. The firm typically invests $5 - 10 million in each company. The firm also has strategic affiliations that provide international co-investment opportunities and flexible sources of capital for larger transactions.
